CALT Calliditas Therapeutics

Watchlist

40.000
0.0000.00%

Trading Sep 20 16:00 ET

1.08BMarket Cap-24.52P/E (TTM)

Calliditas Therapeutics Key Stats

According to the latest financial report of Calliditas Therapeutics, the latest earnings per share (TTM) for the company is -1.76. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: SEK

Quarterly

FCF

Interested in knowing about Calliditas Therapeutics's free cash flow? The latest report shows it as -7.04M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: SEK

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Calliditas Therapeutics shows that the company's current ratio is 2.69, indicating healthy liquidity.

Currency: SEK

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Calliditas Therapeutics, the quick ratio is 2.59, indicating that the company can meet its short-term debt obligations.

Currency: SEK

Quarterly

ROE

Want to learn more about the financial health of Calliditas Therapeutics? The latest ROE figure is -41.84%, indicating that the company has stable profitability.

Currency: SEK

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Calliditas Therapeutics, the total asset return on investment (ROA) is -2.76%.

Currency: SEK

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Calliditas Therapeutics's latest financial report to see how their gross margin is doing - currently at 90.45%.

Currency: SEK

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Calliditas Therapeutics, the net profit margin is -8.48%, which is a good sign for its profitability.

Currency: SEK

Quarterly

Trending US Stocks